University of Washington

University of Washington was paid $129.57M by Medicaid between Jan 2018 and Dec 2024, across 940 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 22% of everything it billed.

33Billing provider infoUNIVERSITY OF WASHINGTON
SEATTLE, WA 98195

33aNPI1326002049assigned 04/12/2006

33bProvider typeClinic Pharmacy

28Total paid$129.57M

24GClaims3,803,449

24DCodes billed940

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Clinic Pharmacy providers in Washington

Rank by total paid#1 of 5

Median peer was paid$15K

This provider vs. median8,615×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	414,876	$15.43M
2019	406,200	$14.52M
2020	510,946	$17.11M
2021	630,150	$21.39M
2022	641,983	$21.95M
2023	654,343	$21.20M
2024incomplete	544,951	$17.96M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	22%	385,039	315,869	$28.57M
J2350	Injection, ocrelizumab, 1 mg	6.7%	715	638	$8.71M
96361	Intravenous infusion, hydration; each additional hour	4.3%	19,886	15,762	$5.54M
77386		2.9%	8,350	731	$3.81M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.2%	29,886	26,265	$2.85M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.1%	38,971	34,869	$2.72M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.0%	21,697	15,324	$2.55M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.8%	33,296	29,847	$2.39M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.7%	10,837	10,427	$2.21M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.6%	14,574	13,808	$2.13M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	1.6%	1,894	599	$2.09M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.6%	1,623	1,539	$2.06M

928 more codes

93451		1.6%	2,038	$2.02M
J2357	Injection, omalizumab, 5 mg	1.4%	2,492	$1.86M
J3380	Injection, vedolizumab, intravenous, 1 mg	1.4%	1,027	$1.81M
J2323	Injection, natalizumab, 1 mg	1.4%	1,263	$1.76M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.3%	7,882	$1.70M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.2%	24,000	$1.61M
59025	Fetal non-stress test	1.0%	8,845	$1.33M
J0585	Injection, onabotulinumtoxina, 1 unit	1.0%	6,634	$1.33M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.0%	5,828	$1.32M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,535	$1.28M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	3,809	$1.26M
70450	Computed tomography, head or brain; without contrast material	<1%	9,753	$1.18M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	48,919	$1.16M
96415		<1%	4,088	$1.08M
Q3014	Telehealth originating site facility fee	<1%	50,315	$1.01M
31579		<1%	3,194	$841K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	9,931	$836K
71275	Computed tomographic angiography, chest, with contrast material	<1%	5,609	$762K
52000		<1%	1,516	$752K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	9,022	$743K
J9271	Injection, pembrolizumab, 1 mg	<1%	183	$740K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	3,142	$733K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	4,688	$686K
64615		<1%	2,878	$657K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	9,741	$638K
76830	Ultrasound, transvaginal	<1%	7,467	$601K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,675	$550K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	17,584	$542K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	5,219	$537K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	6,153	$531K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	16,617	$500K
J2182	Injection, mepolizumab, 1 mg	<1%	419	$493K
80053	Comprehensive metabolic panel	<1%	122,907	$488K
74183		<1%	2,815	$484K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	525	$474K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	3,389	$447K
20610		<1%	2,959	$420K
31231		<1%	2,619	$415K
96130		<1%	681	$412K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	22,861	$406K
20611		<1%	2,078	$396K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,483	$394K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	7,074	$380K
11102		<1%	1,589	$373K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	15,685	$361K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,401	$359K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	6,971	$342K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	13,201	$332K
78815	Positron emission tomography (PET) for limited area imaging	<1%	711	$312K
20553		<1%	2,163	$306K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,582	$293K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,152	$293K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,602	$292K
70496		<1%	1,891	$280K
91010		<1%	921	$277K
74160		<1%	2,074	$274K
43235		<1%	829	$273K
71250		<1%	5,649	$261K
11104		<1%	935	$259K
93308		<1%	1,389	$257K
93970		<1%	3,114	$248K
80048	Basic metabolic panel (calcium, ionized)	<1%	60,476	$248K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	9,796	$243K
11900		<1%	1,335	$239K
77334		<1%	2,104	$237K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	12,703	$234K
77470		<1%	400	$227K
93975		<1%	4,879	$221K
76770		<1%	2,943	$221K
93017		<1%	3,339	$218K
94618		<1%	3,448	$217K
97162		<1%	6,167	$217K
G0378	Hospital observation service, per hour	<1%	7,312	$216K
97161		<1%	5,380	$211K
76536		<1%	2,793	$206K
93971		<1%	2,678	$205K
11100		<1%	674	$205K
72141		<1%	1,808	$204K
70491		<1%	1,923	$198K
76942		<1%	4,115	$195K
76801		<1%	3,683	$195K
74174		<1%	1,760	$192K
77336		<1%	3,337	$191K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,716	$190K
96910		<1%	3,858	$188K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	890	$188K
72197		<1%	1,203	$183K
92557		<1%	3,711	$181K
31237		<1%	229	$180K
77412		<1%	466	$177K
17110		<1%	1,244	$175K
J9035	Injection, bevacizumab, 10 mg	<1%	139	$170K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,959	$167K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,547	$166K
27447		<1%	46	$158K
70486		<1%	2,568	$157K
49083		<1%	506	$152K
36415	Collection of venous blood by venipuncture	<1%	188,435	$150K
97165		<1%	3,943	$147K
77290		<1%	575	$146K
64616		<1%	582	$143K
97802		<1%	3,252	$139K
81420	Fetal chromosomal aneuploidy genomic sequence analysis panel	<1%	1,453	$138K
93978		<1%	2,890	$138K
76882		<1%	1,980	$136K
30140		<1%	96	$136K
97129		<1%	978	$132K
31575		<1%	760	$127K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	12,554	$124K
93325		<1%	5,165	$124K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,039	$124K
97163		<1%	3,179	$124K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	2,499	$123K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	132,130	$123K
76937		<1%	2,894	$121K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	2,412	$120K
90651		<1%	1,472	$118K
G0008	Administration of influenza virus vaccine	<1%	10,418	$113K
97803		<1%	4,462	$112K
J0475	Injection, baclofen, 10 mg	<1%	685	$112K
17000		<1%	1,165	$112K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	<1%	42	$112K
71046	Radiologic examination, chest; 2 views	<1%	19,612	$110K
27130		<1%	24	$109K
96152		<1%	1,165	$108K
97763		<1%	1,096	$105K
90837	Psychotherapy session, about an hour	<1%	1,760	$104K
83880		<1%	15,237	$103K
77080		<1%	2,190	$103K
73221		<1%	716	$102K
36247		<1%	157	$102K
91034		<1%	330	$102K
93505		<1%	1,001	$101K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	31,109	$99K
64643		<1%	452	$97K
77300		<1%	1,287	$93K
93321		<1%	1,610	$90K
84443	Thyroid stimulating hormone (TSH)	<1%	27,482	$88K
93296		<1%	6,810	$86K
36561		<1%	83	$84K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	2,319	$83K
80197		<1%	19,025	$82K
64642		<1%	1,143	$82K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,721	$82K
92524		<1%	2,143	$82K
29581		<1%	757	$81K
76870		<1%	1,084	$81K
90715		<1%	4,708	$80K
88307		<1%	5,875	$80K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,041	$79K
58300		<1%	714	$79K
97535	Self-care/home management training, each 15 minutes	<1%	4,663	$79K
76642		<1%	1,110	$78K
J1756	Injection, iron sucrose, 1 mg	<1%	3,996	$76K
17311		<1%	206	$75K
84484		<1%	21,607	$74K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	59	$72K
72156		<1%	1,114	$72K
72158		<1%	751	$72K
78830		<1%	267	$71K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	50,645	$71K
90472	Immunization administration, each additional vaccine (list separately)	<1%	4,090	$70K
83970		<1%	6,064	$69K
93350		<1%	497	$69K
74178		<1%	522	$68K
96367		<1%	2,419	$65K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	18,265	$65K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	12,149	$63K
93922		<1%	1,311	$63K
36430		<1%	787	$62K
86780		<1%	9,812	$62K
85027		<1%	55,231	$61K
74230		<1%	1,214	$60K
95923		<1%	784	$60K
77338		<1%	101	$60K
80076		<1%	21,003	$59K
80061	Lipid panel	<1%	19,719	$58K
96136		<1%	717	$58K
93320		<1%	3,330	$57K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	178	$56K
87536		<1%	1,780	$55K
94010		<1%	5,567	$54K
96131		<1%	594	$53K
76813		<1%	1,633	$52K
75561		<1%	277	$52K
95885		<1%	504	$52K
88185		<1%	891	$51K
94060		<1%	1,343	$51K
86834		<1%	3,845	$50K
12001		<1%	310	$49K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,651	$49K
82105		<1%	7,349	$49K
87497		<1%	4,308	$49K
93880		<1%	1,046	$49K
G0009	Administration of pneumococcal vaccine	<1%	4,474	$48K
30520		<1%	131	$48K
73030		<1%	7,795	$48K
83605		<1%	10,683	$46K
83036	Hemoglobin; glycosylated (A1C)	<1%	23,363	$46K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	12,586	$45K
97166		<1%	1,412	$45K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,781	$45K
51705		<1%	461	$45K
95117		<1%	2,597	$44K
88142		<1%	3,759	$43K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	4,247	$43K
83735		<1%	53,202	$43K
90834	Psychotherapy session, about 45 minutes	<1%	972	$42K
86480		<1%	4,200	$41K
90686		<1%	4,939	$41K
97116		<1%	2,478	$40K
94660		<1%	211	$40K
87799		<1%	4,148	$39K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,225	$39K
10060		<1%	273	$39K
94729		<1%	3,701	$39K
29888		<1%	13	$39K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	91	$39K
87507		<1%	691	$39K
20550		<1%	228	$38K
93454		<1%	42	$38K
73564		<1%	6,741	$38K
97542		<1%	1,675	$38K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	928	$38K
C9399	Unclassified drugs or biologicals	<1%	2,697	$37K
87522	Neg quan hep c or qual rna	<1%	3,144	$37K
94770		<1%	444	$36K
10061		<1%	184	$36K
J0185	Injection, aprepitant, 1 mg	<1%	502	$36K
J3490	Unclassified drugs	<1%	8,632	$34K
82728		<1%	12,683	$34K
77002		<1%	577	$34K
96158		<1%	379	$34K
52310		<1%	64	$33K
70544		<1%	302	$33K
73130		<1%	4,894	$33K
84439		<1%	8,831	$32K
11045		<1%	146	$32K
85610		<1%	52,115	$32K
87040		<1%	5,833	$31K
74420		<1%	499	$31K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	25,180	$30K
91200		<1%	501	$30K
90674		<1%	2,270	$29K
71045	Radiologic examination, chest; single view	<1%	16,976	$29K
73110		<1%	4,770	$29K
82784		<1%	6,382	$29K
72157		<1%	976	$29K
94726		<1%	1,258	$29K
70498		<1%	1,751	$29K
90670		<1%	2,816	$29K
95924		<1%	736	$28K
92567		<1%	3,122	$28K
72100		<1%	3,625	$28K
86835		<1%	3,845	$28K
82607		<1%	7,258	$27K
87517		<1%	2,528	$27K
87086	Culture, bacterial; quantitative colony count, urine	<1%	25,943	$27K
37243		<1%	37	$27K
73630		<1%	4,133	$26K
70487		<1%	176	$26K
82533		<1%	2,734	$26K
87631		<1%	1,626	$26K
73700		<1%	486	$26K
93976		<1%	286	$26K
95886		<1%	429	$25K
84403		<1%	2,915	$25K
90677		<1%	1,003	$24K
77301		<1%	86	$24K
93246		<1%	841	$23K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	149	$23K
86140		<1%	12,237	$23K
95816		<1%	200	$23K
86235		<1%	3,005	$23K
93242		<1%	910	$23K
96112		<1%	34	$22K
86304		<1%	2,784	$22K
90792	Psychiatric diagnostic evaluation with medical services	<1%	612	$22K
77001		<1%	430	$22K
86803		<1%	11,405	$22K
82570		<1%	17,149	$22K
29075		<1%	84	$21K
92579		<1%	428	$21K
80069		<1%	5,004	$21K
86923		<1%	1,368	$20K
73502		<1%	2,959	$20K
84270		<1%	2,548	$20K
72131		<1%	1,317	$19K
64483		<1%	54	$19K
84702		<1%	15,340	$19K
11056		<1%	288	$19K
10005		<1%	75	$19K
81001		<1%	55,694	$19K
82670		<1%	1,672	$18K
73140		<1%	2,568	$18K
97167		<1%	471	$18K
11721		<1%	1,245	$18K
72195		<1%	111	$18K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	10,616	$17K
51702		<1%	1,479	$17K
82785		<1%	2,478	$17K
78306		<1%	96	$17K
90648		<1%	1,119	$17K
85379		<1%	4,609	$17K
74018		<1%	1,806	$17K
87340		<1%	9,677	$17K
73610		<1%	3,522	$17K
20680		<1%	13	$16K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	2,710	$16K
88342		<1%	4,437	$16K
72110		<1%	1,473	$16K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	418	$15K
84146		<1%	1,743	$15K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	473	$15K
52356		<1%	14	$15K
72040		<1%	1,754	$15K
11055		<1%	188	$14K
86141		<1%	7,569	$14K
51798		<1%	3,746	$14K
84466		<1%	9,084	$14K
88341		<1%	2,819	$14K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,730	$14K
90688		<1%	1,481	$14K
84100		<1%	27,153	$14K
86695		<1%	2,178	$14K
83001		<1%	1,698	$13K
86850		<1%	11,279	$13K
95908		<1%	103	$13K
76820		<1%	714	$13K
58558		<1%	12	$13K
92611		<1%	375	$13K
85652		<1%	16,377	$13K
G2215	Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure	<1%	288	$12K
0124A		<1%	501	$12K
73120		<1%	2,066	$12K
64493		<1%	25	$12K
83520		<1%	5,556	$12K
80180		<1%	3,241	$12K
93247		<1%	533	$12K
86003		<1%	2,762	$12K
0011A		<1%	461	$12K
83540		<1%	9,345	$12K
62369		<1%	249	$12K
0001A		<1%	449	$12K
86900		<1%	13,091	$12K
96375	Therapeutic injection; each additional sequential IV push	<1%	24,160	$12K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	3,445	$11K
77332		<1%	116	$11K
91299		<1%	180	$11K
88313		<1%	2,018	$11K
C1769	Guide wire	<1%	10,863	$11K
76376		<1%	3,678	$11K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	83	$11K
86360		<1%	1,371	$11K
76881		<1%	152	$11K
86706		<1%	7,033	$11K
90480		<1%	998	$11K
93226		<1%	324	$11K
82746		<1%	4,429	$10K
82977		<1%	9,642	$10K
12002		<1%	72	$10K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	481	$10K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	3,760	$10K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	316	$10K
36556		<1%	13	$10K
83516		<1%	4,415	$10K
73080		<1%	2,220	$10K
87116		<1%	1,421	$10K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	412	$10K
86255		<1%	1,066	$10K
99214	Doctor's office visit, returning patient (more involved)	<1%	258	$10K
87081		<1%	6,378	$9K
92610		<1%	467	$9K
90846	Family psychotherapy without the patient present, 50 minutes	<1%	78	$9K
86038		<1%	5,227	$9K
91322		<1%	703	$9K
73562		<1%	814	$9K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	31	$9K
86704		<1%	5,548	$9K
64415		<1%	56	$9K
77280		<1%	66	$9K
84156		<1%	14,031	$9K
86762		<1%	3,770	$9K
74241		<1%	114	$9K
87800		<1%	1,644	$9K
88184		<1%	939	$9K
J2704	Injection, propofol, 10 mg	<1%	39,698	$9K
88350		<1%	1,357	$8K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	36,933	$8K
86481		<1%	698	$8K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	201	$8K
86665		<1%	2,148	$8K
86256		<1%	729	$8K
93243		<1%	356	$8K
83050		<1%	1,194	$8K
J1453	Injection, fosaprepitant, 1 mg	<1%	65	$8K
97130		<1%	961	$8K
92526		<1%	291	$8K
86355		<1%	1,293	$8K
80195		<1%	1,268	$8K
84153		<1%	3,057	$8K
88304		<1%	3,276	$8K
17003		<1%	476	$8K
84630		<1%	1,226	$8K
70543		<1%	52	$8K
86901		<1%	13,402	$8K
64447		<1%	92	$8K
62323		<1%	37	$7K
86644		<1%	1,551	$7K
80143		<1%	2,127	$7K
83010		<1%	1,969	$7K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	1,972	$7K
87077		<1%	9,480	$7K
11720		<1%	606	$7K
82542		<1%	1,128	$7K
88312		<1%	1,952	$7K
96368		<1%	318	$7K
78999		<1%	252	$7K
95910		<1%	49	$7K
51741		<1%	340	$7K
84163		<1%	632	$7K
73560		<1%	2,326	$7K
72128		<1%	873	$7K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	44,803	$7K
87186		<1%	8,798	$7K
36248		<1%	21	$7K
72050		<1%	608	$7K
82550		<1%	5,735	$6K
96137		<1%	715	$6K
87070		<1%	6,644	$6K
81479	Unlisted molecular pathology procedure	<1%	188	$6K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	8,212	$6K
88346		<1%	1,224	$6K
72146		<1%	162	$6K
C8928	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report	<1%	33	$6K
83690		<1%	21,054	$6K
96138		<1%	12	$6K
94621		<1%	71	$6K
76857		<1%	127	$6K
0002A		<1%	188	$6K
82565		<1%	3,581	$6K
85730		<1%	22,988	$6K
93351		<1%	37	$6K
83002		<1%	910	$6K
86696		<1%	2,205	$6K
51700		<1%	119	$6K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	2,497	$5K
C1874	Stent, coated/covered, with delivery system	<1%	569	$5K
97035		<1%	826	$5K
73590		<1%	1,769	$5K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	93	$5K
96150		<1%	67	$5K
99213	Doctor's office visit, returning patient (routine)	<1%	247	$5K
0297T		<1%	316	$5K
76377		<1%	2,207	$5K
86359		<1%	625	$5K
86664		<1%	1,232	$5K
36591		<1%	2,110	$5K
88108		<1%	1,707	$5K
96101		<1%	12	$5K
84480		<1%	1,964	$5K
86334		<1%	882	$5K
93662		<1%	37	$5K
85014		<1%	3,360	$5K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	563	$5K
84165		<1%	2,397	$5K
85018		<1%	6,467	$5K
82103		<1%	634	$5K
90750		<1%	132	$5K
90734		<1%	505	$5K
72070		<1%	555	$5K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	22	$5K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	30	$5K
86769		<1%	384	$5K
93926		<1%	56	$5K
93750		<1%	101	$4K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	7,908	$4K
86160		<1%	2,548	$4K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	26,491	$4K
86376		<1%	298	$4K
91321		<1%	223	$4K
90832	Psychotherapy session, about 30 minutes	<1%	225	$4K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	38,297	$4K
87205		<1%	9,379	$4K
82077		<1%	10,857	$4K
Q0111	Wet mounts, including preparations of vaginal, cervical or skin specimens	<1%	383	$4K
86708		<1%	2,922	$4K
82950		<1%	2,732	$4K
73620		<1%	519	$4K
86777		<1%	1,118	$4K
93225		<1%	318	$4K
90791	Psychiatric diagnostic evaluation	<1%	396	$4K
80164		<1%	981	$4K
58301		<1%	41	$4K
82248		<1%	2,086	$4K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,563	$4K
90732		<1%	479	$4K
82043		<1%	5,007	$4K
86787		<1%	2,359	$4K
73090		<1%	1,126	$4K
82390		<1%	836	$4K
C1776	Joint device (implantable)	<1%	817	$4K
82375		<1%	1,385	$4K
74240		<1%	54	$4K
77370		<1%	27	$4K
58100		<1%	14	$4K
50200		<1%	14	$4K
95115		<1%	185	$4K
89051		<1%	1,394	$4K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	281	$3K
86317		<1%	383	$3K
98968		<1%	887	$3K
91035		<1%	22	$3K
83615		<1%	5,878	$3K
86833		<1%	180	$3K
93925		<1%	83	$3K
86832		<1%	168	$3K
77065	Tomosynthesis, mammo	<1%	121	$3K
96450		<1%	16	$3K
92978		<1%	143	$3K
93798		<1%	800	$3K
11101		<1%	145	$3K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	279	$3K
93356		<1%	1,470	$3K
82677		<1%	162	$3K
57456		<1%	12	$3K
86431		<1%	2,855	$3K
72142		<1%	320	$3K
0054A		<1%	110	$3K
71271		<1%	39	$3K
90707		<1%	391	$3K
92504		<1%	344	$3K
86200		<1%	2,361	$3K
C1726	Catheter, balloon dilatation, non-vascular	<1%	1,411	$3K
J0690	Injection, cefazolin sodium, 500 mg	<1%	13,570	$3K
90636		<1%	180	$3K
70546		<1%	17	$3K
95819		<1%	14	$3K
88112		<1%	1,881	$3K
J1170	Injection, hydromorphone, up to 4 mg	<1%	15,501	$3K
97804		<1%	187	$3K
86147		<1%	337	$3K
0296T		<1%	398	$3K
88323		<1%	135	$3K
81025		<1%	8,323	$3K
84550		<1%	4,148	$3K
87046		<1%	962	$3K
80178		<1%	504	$3K
77066	Tomosynthesis, mammo	<1%	106	$3K
96116		<1%	12	$3K
86828		<1%	248	$3K
83521		<1%	1,188	$3K
95874		<1%	2,365	$3K
82803		<1%	4,213	$3K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	8,080	$2K
72082		<1%	224	$2K
87147		<1%	3,512	$2K
82947		<1%	2,531	$2K
80179		<1%	1,441	$2K
0064A		<1%	116	$2K
92552		<1%	25	$2K
86225		<1%	2,058	$2K
80306		<1%	3,154	$2K
90662		<1%	798	$2K
96376		<1%	8,483	$2K
80162		<1%	285	$2K
87102		<1%	3,330	$2K
51728		<1%	12	$2K
92083		<1%	671	$2K
86146		<1%	338	$2K
11103		<1%	78	$2K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	25,689	$2K
87015		<1%	2,288	$2K
12011		<1%	12	$2K
73222		<1%	13	$2K
92587		<1%	25	$2K
90656		<1%	552	$2K
84134		<1%	1,283	$2K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	1,488	$2K
86765		<1%	1,533	$2K
0004A		<1%	77	$2K
82525		<1%	355	$2K
82962		<1%	17,021	$2K
73701		<1%	13	$2K
73200		<1%	24	$2K
86364		<1%	763	$2K
87593		<1%	33	$2K
86735		<1%	1,240	$2K
87075		<1%	3,248	$2K
87088		<1%	3,358	$2K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	1,175	$2K
0154A		<1%	45	$2K
75574		<1%	12	$2K
C1753	Catheter, intravascular ultrasound	<1%	799	$2K
88348		<1%	80	$2K
72170		<1%	601	$2K
0031A		<1%	40	$2K
73552		<1%	673	$2K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	13,928	$2K
88360		<1%	161	$2K
69210		<1%	27	$2K
75572		<1%	13	$1K
C1760	Closure device, vascular (implantable/insertable)	<1%	1,786	$1K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	14,795	$1K
85384		<1%	1,803	$1K
83051		<1%	778	$1K
82150		<1%	731	$1K
84481		<1%	495	$1K
92523		<1%	12	$1K
97760		<1%	54	$1K
92133		<1%	987	$1K
92537		<1%	31	$1K
73521		<1%	123	$1K
70549		<1%	13	$1K
86258		<1%	453	$1K
76819	Fetal biophysical profile; without non-stress testing	<1%	45	$1K
80047		<1%	546	$1K
81002		<1%	2,067	$1K
75565		<1%	420	$1K
95909		<1%	13	$1K
84295		<1%	2,098	$1K
74328		<1%	24	$1K
99001		<1%	97	$1K
82140		<1%	491	$1K
J7050	Infusion, normal saline solution, 250 cc	<1%	20,482	$1K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	784	$1K
0111A		<1%	27	$1K
J7030	Infusion, normal saline solution , 1000 cc	<1%	15,489	$1K
73060		<1%	608	$1K
82575		<1%	794	$1K
84166		<1%	150	$1K
83655		<1%	94	$1K
0081A		<1%	25	$1K
82274		<1%	263	$1K
77331		<1%	27	$988.44
88300		<1%	753	$976.67
82365		<1%	160	$975.25
84202		<1%	75	$968.52
J3370	Injection, vancomycin hcl, 500 mg	<1%	5,174	$946.82
84305		<1%	109	$899.83
96132		<1%	13	$899.51
76872		<1%	27	$875.25
82378		<1%	196	$864.55
82330		<1%	2,245	$862.18
86357		<1%	124	$837.83
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	14,926	$837.28
86036		<1%	638	$834.33
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	293	$818.84
82805		<1%	333	$803.41
90746		<1%	55	$800.28
J3489	Injection, zoledronic acid, 1 mg	<1%	15	$797.30
J3111	Injection, romosozumab-aqqg, 1 mg	<1%	13	$795.87
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	39	$795.71
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	1,976	$783.03
84460		<1%	1,099	$761.36
Q0112	All potassium hydroxide (koh) preparations	<1%	108	$757.28
83013		<1%	38	$718.39
J2785	Injection, regadenoson, 0.1 mg	<1%	1,431	$704.28
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	177	$702.04
85046		<1%	1,746	$696.38
88720		<1%	194	$695.73
84450		<1%	796	$693.43
94799		<1%	242	$676.92
80305		<1%	330	$671.07
87206		<1%	1,309	$669.45
84378		<1%	408	$665.09
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,743	$662.02
96159		<1%	299	$639.16
99385		<1%	12	$626.49
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	12	$617.40
84132		<1%	2,760	$613.32
82247		<1%	279	$606.74
84446		<1%	223	$603.95
62370		<1%	16	$600.07
93280		<1%	102	$587.08
92540		<1%	31	$585.79
J1644	Injection, heparin sodium, per 1000 units	<1%	10,160	$585.26
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,752	$582.29
86015		<1%	245	$581.99
87210		<1%	1,284	$572.44
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,724	$569.02
88738		<1%	200	$567.55
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	6,731	$554.28
80175		<1%	123	$549.25
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	145	$545.81
93041		<1%	3,772	$532.40
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	102	$529.83
86778		<1%	55	$520.25
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	51	$506.07
80299		<1%	85	$501.56
72147		<1%	189	$491.04
0072A		<1%	12	$487.20
0003A		<1%	22	$486.00
92548		<1%	14	$479.38
C1729	Catheter, drainage	<1%	1,609	$458.13
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	663	$445.25
83020		<1%	121	$432.61
73522		<1%	58	$428.24
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,588	$420.34
C2628	Catheter, occlusion	<1%	490	$416.66
92551		<1%	13	$412.52
81003		<1%	963	$404.81
87181		<1%	303	$402.00
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,289	$401.39
96417		<1%	1,206	$381.61
82627		<1%	53	$381.06
87106		<1%	721	$374.67
86336		<1%	164	$372.62
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	12	$372.20
0171A		<1%	15	$368.40
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,580	$366.59
86800		<1%	64	$365.27
94761		<1%	2,913	$360.66
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,967	$357.64
84590		<1%	154	$353.37
84080		<1%	79	$329.76
98967		<1%	242	$328.95
82465		<1%	241	$326.92
C2625	Stent, non-coronary, temporary, with delivery system	<1%	262	$324.68
M0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring	<1%	78	$314.97
96402		<1%	151	$308.91
51797		<1%	12	$305.92
86352		<1%	56	$301.04
90632		<1%	29	$298.00
J1815	Injection, insulin, per 5 units	<1%	5,151	$297.57
78205		<1%	35	$296.96
36600		<1%	124	$291.34
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,653	$289.23
86308		<1%	356	$288.84
73000		<1%	52	$288.56
86413		<1%	114	$276.81
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	67	$266.40
87184		<1%	681	$266.14
17312		<1%	18	$265.93
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	5,098	$256.62
82172		<1%	32	$248.52
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,852	$244.64
87176		<1%	410	$243.58
86592		<1%	153	$238.34
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,715	$236.96
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,026	$236.44
81229		<1%	13	$229.20
86381		<1%	160	$227.49
C1788	Port, indwelling (implantable)	<1%	86	$222.58
83014		<1%	38	$219.78
80158		<1%	29	$217.07
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,476	$215.69
90678		<1%	75	$213.45
85670		<1%	753	$212.47
84425		<1%	59	$211.22
87481		<1%	44	$210.99
77091		<1%	60	$198.85
88173		<1%	471	$198.08
86870		<1%	32	$194.92
82945		<1%	203	$188.84
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	12	$187.03
84157		<1%	200	$186.22
C9290	Injection, bupivacaine liposome, 1 mg	<1%	317	$183.17
83883		<1%	14	$179.46
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	1,513	$178.19
C1819	Surgical tissue localization and excision device (implantable)	<1%	425	$176.46
C2617	Stent, non-coronary, temporary, without delivery system	<1%	787	$174.73
84145		<1%	13	$174.24
82010		<1%	626	$173.89
90694		<1%	299	$172.44
36592		<1%	184	$169.88
82104		<1%	27	$166.44
84478		<1%	284	$163.60
90474		<1%	800	$147.94
83021		<1%	47	$139.88
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	879	$137.28
82787		<1%	40	$136.31
87806		<1%	1,008	$136.06
73100		<1%	45	$130.25
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,198	$125.27
83993		<1%	12	$123.99
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,040	$121.98
82085		<1%	42	$117.72
J8501	Aprepitant, oral, 5 mg	<1%	939	$116.82
82523		<1%	15	$115.82
J1790	Injection, droperidol, up to 5 mg	<1%	865	$114.43
J1171	Injection, hydromorphone, 0.1 mg	<1%	480	$114.40
96133		<1%	17	$108.88
90647		<1%	36	$107.80
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	478	$102.16
51701		<1%	175	$89.99
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	3,791	$88.96
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	160	$85.07
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	6,303	$83.90
J1940	Injection, furosemide, up to 20 mg	<1%	801	$83.20
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,853	$81.87
82310		<1%	69	$80.91
86709		<1%	56	$80.34
85049		<1%	135	$77.62
91300		<1%	797	$77.58
96040		<1%	68	$71.59
82040		<1%	183	$69.20
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,743	$69.12
J8540	Dexamethasone, oral, 0.25 mg	<1%	881	$67.49
91301		<1%	494	$64.73
76000		<1%	54	$64.11
J2060	Injection, lorazepam, 2 mg	<1%	2,641	$60.96
82239		<1%	28	$59.15
87529		<1%	30	$58.94
84436		<1%	14	$54.76
84300		<1%	52	$54.20
94727		<1%	16	$53.52
87999		<1%	25	$52.48
94760		<1%	364	$52.28
87220		<1%	97	$47.92
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	1,792	$44.88
92134		<1%	31	$44.17
82166		<1%	14	$34.91
88302		<1%	16	$33.08
J3480	Injection, potassium chloride, per 2 meq	<1%	2,218	$32.08
J1630	Injection, haloperidol, up to 5 mg	<1%	1,195	$30.33
J3360	Injection, diazepam, up to 5 mg	<1%	249	$29.40
87493		<1%	12	$29.30
90716		<1%	176	$28.04
84681		<1%	14	$27.15
A9270	Non-covered item or service	<1%	32,488	$27.02
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	52	$26.43
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	66	$25.11
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	789	$24.14
81000		<1%	445	$23.03
C1892	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away	<1%	33	$18.93
84520		<1%	12	$17.22
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	233	$16.81
82948		<1%	134	$15.29
86682		<1%	13	$14.91
83930		<1%	32	$14.29
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,153	$14.17
0097U		<1%	151	$13.54
90723		<1%	704	$8.92
85130		<1%	168	$8.10
81374		<1%	25	$7.38
C1781	Mesh (implantable)	<1%	264	$6.99
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	974	$5.92
36416		<1%	1,362	$5.38
C1758	Catheter, ureteral	<1%	987	$4.76
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	561	$4.14
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,393	$4.11
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	1,021	$3.21
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	479	$2.20
A4344	Indwelling catheter, foley type, two-way, all silicone or polyurethane, each	<1%	51	$1.48
99072		<1%	86	$1.06
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	232	$0.72
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	379	$0.64
C2627	Catheter, suprapubic/cystoscopic	<1%	81	$0.43
Q0221	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg	<1%	79	$0.26
J3411	Injection, thiamine hcl, 100 mg	<1%	1,122	$0.20
90633		<1%	994	$0.01
90680		0%	1,002	$0.00
90697		0%	440	$0.00
J2305	Injection, nitroglycerin, 5 mg	0%	221	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	344	$0.00
90696		0%	52	$0.00
J1836	Injection, metronidazole, 10 mg	0%	497	$0.00
90381		0%	41	$0.00
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	0%	1,059	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	60	$0.00
81511		0%	117	$0.00
91315		0%	44	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	226	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	260	$0.00
J1250	Injection, dobutamine hydrochloride, per 250 mg	0%	26	$0.00
G0010	Administration of hepatitis b vaccine	0%	99	$0.00
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	0%	2,616	$0.00
J1805	Injection, esmolol hydrochloride, 10 mg	0%	59	$0.00
91317		0%	69	$0.00
90698		0%	109	$0.00
C1759	Catheter, intracardiac echocardiography	0%	13	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	17	$0.00
J9045	Injection, carboplatin, 50 mg	0%	170	$0.00
91305		0%	216	$0.00
A4340	Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each	0%	14	$0.00
J7507	Tacrolimus, immediate release, oral, 1 mg	0%	38	$0.00
J0456	Injection, azithromycin, 500 mg	0%	20	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	74	$0.00
38900		0%	27	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	12	$0.00
G8991	Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	13	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	111	$0.00
88311		0%	15	$0.00
91306		0%	53	$0.00
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	0%	13	$0.00
81370		0%	13	$0.00
91303		0%	40	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	23	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	17	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	12	$0.00
96139		0%	12	$0.00
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	0%	429	$0.00
C1731	Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)	0%	79	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	241	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	2,764	$0.00
91311		0%	68	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	172	$0.00
90836		0%	204	$0.00
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	0%	450	$0.00
J0290	Injection, ampicillin sodium, 500 mg	0%	14	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	83	$0.00
91308		0%	109	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	442	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	177	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	178	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	29	$0.00
90681		0%	261	$0.00
76098		0%	12	$0.00
A4346	Indwelling catheter; foley type, three way for continuous irrigation, each	0%	201	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	422	$0.00
91312		0%	518	$0.00
90700		0%	70	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	16	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	215	$0.00
90611		0%	63	$0.00
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	0%	521	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	156	$0.00
90710		0%	83	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	89	$0.00
J2720	Injection, protamine sulfate, per 10 mg	0%	16	$0.00
J2598	Injection, vasopressin, 1 unit	0%	112	$0.00
94690		0%	13	$0.00
G8990	Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals	0%	13	$0.00
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	0%	13	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	19	$0.00
90838		0%	21	$0.00
77387		0%	71	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHWILKE, BRENDA (SR. DIRECTOR REVENUE INTEGRITY)

Same official

Other billing entities under SCHWILKE, BRENDA

Full network →

Provider	Location	Paid
Harborview Medical Center	Seattle, WA	$128.05M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.